This product is made from peptides derived from human cathelicidins, supplemented with immunomodulatory activators such as T-activin, IL-2, IL-6, and TNF-α.

LL-37 is used clinically for immune modulation and antimicrobial support, helping the body defend against bacterial, viral, and fungal infections.

It is applied in cases of chronic or difficult-to-treat infections and biofilm-related conditions due to its ability to disrupt microbial membranes and enhance innate immune activity.

Additional clinical applications include supporting wound healing, reducing inflammation, promoting epithelial repair, and improving overall tissue recovery and immune resilience.